Abbott Laboratories Form 4 insider transactions

Abbott Laboratories CEO Robert Ford disposed of 31,610 common shares to cover tax obligations, while still holding a significant number of shares directly and indirectly through a family trust.

Executive Vice President of Abbott Laboratories, Lisa D. Earnhardt, reports the disposition and acquisition of company stock.

Senior Vice President Philip P. Boudreau reports disposition of Abbott Laboratories shares to cover tax obligations.

Executive Vice President Hubert L. Allen reports the disposition of Abbott Laboratories shares on February 29, 2024, and March 1, 2024.

Executive Vice President of Abbott Laboratories, Andrea F. Wainer, reports exercising stock options and selling shares on February 23, 2024.